03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Noroxin : | |
Type | Medicine Authorised |
Originator | B |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Algorithm Laboratories |
Responsible Party | Algorithm S.A.L. |
Origin | Lebanon |
Manufacturer | Algorithm Pharmaceutical Manufacturers |
Origin | Lebanon |
ATC | J01MA06 |
Revision Date | 01/06/2010 |
Noroxin :
Noroxin :
Noroxin :
Noroxin :
Noroxin :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Noroxin :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abdominal spasm | Common |
Agranulocytosis | Not known |
ALT increased | Rare |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anorexia | Very rare |
Anxiety | Very rare |
Arthralgia (Pain joint) (Joint ache) | Not known |
Arthritis | Not known |
AST increased | Rare |
Blood creatine phosphokinase increased | Not known |
Cephalea | Common |
Confusion | Not known |
Convulsion | Not known |
Depression | Very rare |
Dermatitis exfoliative | Not known |
Diarrhoea (Diarrhea) | Common |
Disorientation | Very rare |
Dizziness | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Not known |
Dyspnoea (dyspnea) | Not known |
Eosinophilia | Rare |
Epigastric burning | Common |
Erythema multiforme | Not known |
Euphoria | Very rare |
Glucose-6-phosphate dehydrogenase abnormal (G6PD) | Not known |
Guillain-Barre syndrome | Not known |
Haemolytic anemia | Not known |
Hallucination | Very rare |
Hearing loss | Not known |
Hepatitis | Not known |
Hypersensitivity reactions | Not known |
Hypoesthesia | Not known |
Interstitial nephritis | Not known |
Irritability | Very rare |
Jaundice | Not known |
Jaundice cholestatic (Cholestatic icterus) | Not known |
Lacrimation increased (Epiphora) | Very rare |
Leucopenia (Leukopenia) | Rare |
Liver function test abnormal | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Myalgia | Not known |
Myasthenia gravis aggravated | Not known |
Myoclonus | Not known |
Nausea | Common |
Nervousness | Very rare |
Neutropenia | Rare |
Pancreatitis | Rare |
Paraesthesia (paresthesia) | Not known |
Photosensitivity | Not known |
Polyneuropathy | Not known |
Pruritus | Not known |
Pseudomembranous colitis | Not known |
Psychic disturbance | Not known |
Psychotic reactions | Not known |
Renal insufficiency | Not known |
Skin rash | Common |
Sleep disorder (Sleep disturbance) | Very rare |
Stevens-Johnson syndrome | Not known |
Tendinitis (Tendonitis) | Not known |
Tendon rupture | Not known |
Thrombocytopenia (Thrombopenia) | Rare |
Tinnitus | Very rare |
Tremor | Not known |
Urticaria | Not known |
Vaginal candidiasis | Not known |
Vasculitis | Not known |
Visual disturbance | Not known |
Noroxin :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Noroxin MoH 4327 :
Form | Tablet, Scored |
Packaging | Blisters (Al/PVC) |
Package Size | Box of 14 |
Strength | 400mg |
Storage Condition | <30°C protect from humidity & light |
Public Price | 574652.65 L.L. |
Stratum | A1 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 25618 |
Submission date | 01/01/1991 |
Registration Year | 1991 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File